A1C or A1c) Immunogen Synthetic Peptide Clone Number SDT-192-53 Antibody Type Recombinant mAb Isotype IgG Application Sandwich ELISA Reactivity Hu Predicted Reactivity Ms Cross Reactivity Does not recognize hemoglobin Purification Protein A Concentration 2 mg/ml Purity >95% by HPLC Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS pH7
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine)
we have identified 12 positively selected sites in the G protein ectodomain
Components 25T 100T Annexin V-PE 150uL 500uL 7-AAD 300uL 1mL 5 × Binding buffer 5mL 15mL Apoptosis Positive Control Solution 5mL 5mL PubChem CID 0 General Notes 1
Species HPV Amino Acid Sequence TLQDIVLHL
M-CSFR His Tag Protein, Cynomolgus Size:100μg A1C or A1c) Immunogen SyntheticProduct Specification Species Cynomolgus Synonyms M CSFR, CD115, FIM2, FMS, CSF1R Accession G7P8P1 Amino Acid Sequence Ile99 Pro596, with C 8*His Expression System HEK293 Molecular Weight 80 95kDa Purity >95% by SDS PAGE Endotoxin <0. 1EU g Conjugation Unconjugated Tag His Tag Physical Appearance Lyophilized Powder Storage Buffer PBS, pH7. 4 Reconstitution Reconstitute at 0. 1 1 mg ml according to the size in ultrapure water after rapid